Andrew N Stephens (Andrew Stephens, Stephens Andrew N)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Topics

Silver Nanoparticles

Top Venues

Diagnostics (Basel, Switzerland)

International journal of molecular sciences

Metallomics : integrated biometal science

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew N Stephens, Simon J Hobbs, Sung-Woog Kang, Martin K Oehler, Tom W Jobling, Richard Allman
ReClassification of Patients with Ambiguous CA125 for Optimised Pre-Surgical Triage. Diagnostics (Basel, Switzerland) 14 (7) (2024)
Andrew N Stephens, Simon J Hobbs, Sung-Woog Kang, Martin K Oehler, Tom W Jobling, Richard Allman
ReClassification of Patients with Ambiguous CA125 for Optimised Pre-Surgical Triage. Diagnostics (Basel, Switzerland) 14 (7) (2024)
Andrew N Stephens, Simon J Hobbs, Sung-Woog Kang, Martin K Oehler, Tom W Jobling, Richard Allman
Utility of a Multi-Marker Panel with Ultrasound for Enhanced Classification of Adnexal Mass. Cancers 16 (11) (2024)
Andrew N Stephens, Simon J Hobbs, Sung-Woog Kang, Martin K Oehler, Tom W Jobling, Richard Allman
ReClassification of Patients with Ambiguous CA125 for Optimised Pre-Surgical Triage. Diagnostics (Basel, Switzerland) 14 (7) (2024)
Andrew N Stephens, Simon J Hobbs, Sung-Woog Kang, Martin K Oehler, Tom W Jobling, Richard Allman
Utility of a Multi-Marker Panel with Ultrasound for Enhanced Classification of Adnexal Mass. Cancers 16 (11) (2024)
Nirmala Chandralega Kampan, Apriliana Ellya Ratna Kartikasari, Cyril Deceneux, Mutsa Tatenda Madondo, Orla M McNally, Katie Louise Flanagan, Norhaslinda A Aziz, Andrew N Stephens, John Reynolds, Michael A Quinn, Magdalena Plebanski
Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses. Cancers 15 (3) (2023)
Nirmala Chandralega Kampan, Apriliana Ellya Ratna Kartikasari, Cyril Deceneux, Mutsa Tatenda Madondo, Orla M McNally, Katie Louise Flanagan, Norhaslinda A Aziz, Andrew N Stephens, John Reynolds, Michael A Quinn, Magdalena Plebanski
Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses. Cancers 15 (3) (2023)
Andrew N Stephens, Simon J Hobbs, Sung-Woon Kang, Maree Bilandzic, Adam Rainczuk, Martin K Oehler, Tom W Jobling, Magdalena Plebanski, Richard Allman
A Novel Predictive Multi-Marker Test for the Pre-Surgical Identification of Ovarian Cancer. Cancers 15 (21) (2023)
Nedaossadat Mirzadeh, Srinivasa Reddy Telukutla, Rodney B Luwor, Steven H Privér, Ganga Reddy Velma, Ranjith Kumar Jakku, Andrew N Stephens, Magdalena Plebanski, Christian G Hartinger, Suresh Kumar Bhargava
Dinuclear orthometallated gold(I)-gold(III) anticancer complexes with potent in vivo activity through an ROS-dependent mechanism. Metallomics : integrated biometal science 13 (7) (2022)
Noor A Lokman, Carmela Ricciardelli, Andrew N Stephens, Thomas W Jobling, Peter Hoffmann, Martin K Oehler
Diagnostic Value of Plasma Annexin A2 in Early-Stage High-Grade Serous Ovarian Cancer. Diagnostics (Basel, Switzerland) 11 (1) (2021)
Amy L Wilson, Laura R Moffitt, Kirsty L Wilson, Maree Bilandzic, Mark D Wright, Mark D Gorrell, Martin K Oehler, Magdalena Plebanski, Andrew N Stephens
DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model. Cancers 13 (3) (2021)
Rhiane Moody, Kirsty Wilson, Nirmala Chandralega Kampan, Orla M McNally, Thomas W Jobling, Anthony Jaworowski, Andrew N Stephens, Magdalena Plebanski
Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This Malignancy. Cancers 13 (16) (2021)
Sung-Woog Kang, Adam Rainczuk, Martin K Oehler, Thomas W Jobling, Magdalena Plebanski, Andrew N Stephens
Active Ratio Test (ART) as a Novel Diagnostic for Ovarian Cancer. Diagnostics (Basel, Switzerland) 11 (6) (2021)
Laura R Moffitt, Maree Bilandzic, Amy L Wilson, Yiqian Chen, Mark D Gorrell, Martin K Oehler, Magdalena Plebanski, Andrew N Stephens
Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer Cells. International journal of molecular sciences 21 (21) (2020)
Dane Cheasley, Matthew J Wakefield, Georgina L Ryland, Prue E Allan, Kathryn Alsop, Kaushalya C Amarasinghe, Sumitra Ananda, Michael S Anglesio, George Au-Yeung, Maret Böhm, David D L Bowtell, Alison Brand, Georgia Chenevix-Trench, Michael Christie, Yoke-Eng Chiew, Michael Churchman, Anna De Fazio, Renee Demeo, Rhiannon Dudley, Nicole Fairweather, Clare G Fedele, Sian Fereday, Stephen B Fox, C Blake Gilks, Charlie Gourley, Neville F Hacker, Alison M Hadley, Joy Hendley, Gwo-Yaw Ho, Siobhan Hughes, David G Hunstman, Sally M Hunter, Tom W Jobling, Kimberly R Kalli, Scott H Kaufmann, Catherine J Kennedy, Martin Koebel, Cécile Lepage, Jason Li, Richard Lupat, Orla M McNally, Jessica Nell McAlpine, Anne-Marie Mes-Masson, Linda Mileshkin, Diane M Provencher, Jan Pyman, Kurosh Rahimi, Simone M Rowley, Carolina Salazar, Goli Samimi, Hugo Saunders, Timothy Semple, Ragwha Sharma, Alice J Sharpe, Andrew N Stephens, Niko Thio, Michelle C Torres, Nadia Traficante, Zhongyue Xing, Magnus Zethoven, Yoland C Antill, Clare L Scott, Ian G Campbell, Kylie L Gorringe
The molecular origin and taxonomy of mucinous ovarian carcinoma. Nature communications 10 (1) (2019)
Laura Moffitt, Nazanin Karimnia, Andrew N Stephens, Maree Bilandzic
Therapeutic Targeting of Collective Invasion in Ovarian Cancer. International journal of molecular sciences 20 (6) (2019)
Maree Bilandzic, Adam Rainczuk, Emma Green, Nicole Fairweather, Thomas W Jobling, Magdalena Plebanski, Andrew N Stephens
Keratin-14 (KRT14) Positive Leader Cells Mediate Mesothelial Clearance and Invasion by Ovarian Cancer Cells. Cancers 11 (9) (2019)
Amy L Wilson, Kirsty L Wilson, Maree Bilandzic, Laura R Moffitt, Ming Makanji, Mark D Gorrell, Martin K Oehler, Adam Rainczuk, Andrew N Stephens, Magdalena Plebanski
Non-Invasive Fluorescent Monitoring of Ovarian Cancer in an Immunocompetent Mouse Model. Cancers 11 (1) (2018)